Date | Name | Activity | Value |
---|---|---|---|
Aug 29, 2023 | Deborah Weitzman Ceo, Pharmaceutical Segment | Sold | $602805 |
Aug 21, 2023 | Sold | $1785358 | |
Aug 17, 2023 | Sold | $288795 | |
Aug 17, 2023 | Stephen M Mason Ceo, Medical Segment | Sold | $5664578 |
Date | Firm | Activity | Value |
---|---|---|---|
Dec 31, 2023 | Bought | $202003 | |
Dec 31, 2023 | Bought | $225590 | |
Dec 31, 2023 | Bought | $226598 | |
Dec 31, 2023 | Bought | $289497 |
Holder | # of Shares | Type | % Holding | Value |
---|---|---|---|---|
27,538,315 | Institution | 11.32% | 2,824,329,586 | |
23,487,407 | Institution | 9.66% | 2,408,868,462 | |
10,773,117 | Institution | 4.43% | 1,104,890,880 | |
9,979,899 | Institution | 4.10% | 1,023,538,441 | |
4,102,378 | Institution | 1.69% | 420,739,888 | |
3,982,028 | Institution | 1.64% | 408,396,792 | |
3,375,553 | Institution | 1.39% | 346,196,755 | |
2,000,000 | Institution | 0.82% | 205,120,000 | |
1,830,378 | Institution | 0.75% | 187,723,568 | |
1,797,048 | Institution | 0.74% | 184,305,243 |
Holder | # of Shares | Type | % Holding | Value |
---|---|---|---|---|
23,487,407 | Institution | 9.66% | 2,408,868,462 | |
4,102,378 | Institution | 1.69% | 420,739,888 | |
1,830,378 | Institution | 0.75% | 187,723,568 | |
1,797,048 | Institution | 0.74% | 184,305,243 | |
1,538,106 | Institution | 0.63% | 157,748,151 | |
1,437,141 | Institution | 0.59% | 147,393,181 | |
1,188,558 | Institution | 0.49% | 121,898,508 | |
1,084,375 | Institution | 0.45% | 111,213,500 | |
1,031,317 | Institution | 0.42% | 105,771,872 | |
1,026,365 | Institution | 0.42% | 105,263,994 |
Holder | # of Shares | Type | % Holding | Value |
---|